Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,728,529 papers from all fields of science
Search
Sign In
Create Free Account
Tegafur
Known as:
1-(Tetrahydro-2-furanyl)-5-fluorouracil
, Tegafur [Chemical/Ingredient]
, 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione
Expand
A congener of the antimetabolite fluorouracil with antineoplastic activity. Tegafur is a prodrug that is gradually converted to fluorouracil in the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
37 relations
Narrower (24)
3-FT
ACFM protocol
BMFt protocol
COPU protocol
Expand
Broader (1)
Antimetabolites, Antineoplastic
In Blood
NCIt Antineoplastic Agent Terminology
agonists
analogs & derivatives
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
Improved survival with oral administration of enteric‐coated tegafur/uracil for advanced stage IV‐A hepatocellular carcinoma
T. Ishikawa
,
T. Ichida
,
+8 authors
H. Asakura
Journal of Gastroenterology and Hepatology
2001
Corpus ID: 573651
Background and Aims: There is currently no proven chemotherapy regimen for hepatocellular carcinoma (HCC). The principal…
Expand
Highly Cited
1995
Highly Cited
1995
Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
K. Takenaka
,
K. Yoshida
,
+4 authors
K. Sugimachi
American Journal of Surgery
1995
Corpus ID: 23760455
1990
1990
Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma.
Y. Maehara
,
A. Watanabe
,
Y. Kakeji
,
H. Baba
,
S. Kohnoe
,
K. Sugimachi
American Journal of Surgery
1990
Corpus ID: 35229790
Review
1987
Review
1987
Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
T. Taguchi
Cancer detection and prevention. Supplement…
1987
Corpus ID: 13191737
Highly Cited
1984
Highly Cited
1984
Postoperative adjuvant chemotherapy for gastric carcinoma analysis of data on 1805 patients followed for 5 years
K. Inokuchi
,
T. Hattori
,
T. Taguchi
,
O. Abe
,
N. Ogawa
Cancer
1984
Corpus ID: 1091396
The effectiveness of combination chemotherapy with mitomycin‐C (MMC) plus Futraful (N1‐(2′‐tetrahydrofuryl)‐5‐fluorouracil) for…
Expand
Highly Cited
1983
Highly Cited
1983
Phase I-II studies of oral tegafur (ftorafur).
F. Ansfield
,
G. J. Kallas
,
J. P. Singson
Journal of Clinical Oncology
1983
Corpus ID: 23164536
A total of 65 patients with advanced colorectal or breast cancer were given oral tegafur in the phase I study. Of these, 28…
Expand
1979
1979
Effect of Coadministration of Uracil or Cytosine on the Antitumor Activity of Clinical Doses of 1-(2-Tetrahydrofuryl)-5-Fluorouracil and Level of 5-Fluorouracil in Rodents
藤井 節郎
1979
Corpus ID: 82511046
Highly Cited
1978
Highly Cited
1978
Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.
J. Benvenuto
,
K. Lu
,
S. Hall
,
R. Benjamin
,
T. L. Loo
Cancer Research
1978
Corpus ID: 36228745
The pharmacology of high-dose 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT) has been studied by radiochemical and chromatographic…
Expand
1978
1978
Experimental chemotherapy of carcinoma of the human stomach and colon serially transplanted in nude mice.
T. Kubota
,
Y. Shimosato
,
K. Nagai
Gan
1978
Corpus ID: 9870839
Human gastric and colon carcinomas serially transplantable in nude mice, designated as St-4, St-15, and Co-3, were used for…
Expand
1976
1976
Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors.
A. Hoshi
,
M. Iigo
,
A. Nakamura
,
M. Yoshida
,
K. Kuretani
Gan
1976
Corpus ID: 12270118
Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil against various tumors was examined. Therapeutic ratio (ILSmax/ILS30) in L…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE